Drug Shortage Report for GD-AZITHROMYCIN

Last updated on 2017-05-06 History
Report ID 8733
Drug Identification Number 02274574
Brand name GD-AZITHROMYCIN
Common or Proper name GD-AZITHROMYCIN
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Active Ingredient(s) AZITHROMYCIN
Strength(s) 200MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size 600mg/15mL
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-04-21
Estimated end date 2017-05-16
Actual end date 2017-05-05
Shortage status Resolved
Updated date 2017-05-06
Company comments Resolved May 5, 2017
Health Canada comments
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-05-06 English Compare
v6 2017-05-05 French Compare
v5 2017-05-05 English Compare
v4 2017-05-02 French Compare
v3 2017-05-02 English Compare
v2 2017-05-02 French Compare
v1 2017-05-02 English Compare